Loading...
Metformin: A Potential Therapeutic Tool for Rheumatologists
Metformin is an oral antihyperglycemic drug widely used to treat type 2 diabetes, acting via indirect activation of 5′ Adenosine Monophosphate-activated Protein Kinase (AMPK). Actually, evidence has accumulated of an intriguing anti-inflammatory activity, mainly mediated by AMPK through a variety of...
Saved in:
| Published in: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7560003/ https://ncbi.nlm.nih.gov/pubmed/32899806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13090234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|